GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea · Delayed Price · Currency is KRW 4,255.00
+15.00 (0.35%)
At close: Jan 21, 2026
GeneBioTech Co. ,Ltd Market Cap
GeneBioTech Co. ,Ltd has a market cap or net worth of 36.64 billion as of January 23, 2026. Its market cap has increased by 28.36% in one year.
Market Cap
36.64B
Enterprise Value
28.63B
Revenue
92.28B
Ranking
n/a
PE Ratio
9.95
Stock Price
4,255.00
Market Cap Chart
Since April 28, 2006, GeneBioTech Co. ,Ltd's market cap has increased from 35.91B to 36.64B, an increase of 2.02%. That is a compound annual growth rate of 0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 36.64B | 6.11% |
| Dec 30, 2025 | 34.53B | 21.88% |
| Dec 30, 2024 | 28.33B | -24.54% |
| Dec 28, 2023 | 37.54B | 9.27% |
| Dec 29, 2022 | 34.36B | -23.85% |
| Dec 30, 2021 | 45.12B | -8.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RP Bio | 54.51B |
| Eagle Veterinary Technology Co.,Ltd | 51.64B |
| Kyung Nam Pharm | 47.44B |
| Korean Drug | 44.79B |
| HLscience | 40.74B |
| Seoul Pharma | 34.28B |
| ChoA Pharmaceutical Co., LTD. | 27.54B |
| Daesung Microbiological Labs. | 26.83B |